TritonPoint Partners »

Halozyme Therapeutics shares owned by TritonPoint Partners

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by TritonPoint Partners from 13F filings

Historical chart of TritonPoint Partners investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by TritonPoint Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by TritonPoint Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $239k 3.7k 64.62

More positions owned by TritonPoint Partners

Spdr Series Trust State Street Spd (BIL)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr Series Trust State Street Spd (SPYG)
Microsoft Corporation (MSFT)
Blackrock Etf Trust Ii Ishares Flexible (BINC)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Spdr Series Trust State Street Spd (SPYV)
Ishares Tr Hdg Msci Eafe (HEFA)
Ishares Tr Core Us Aggbd Et (AGG)

View all positions for TritonPoint Partners

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Invesco
Arrowstreet Capital, Limited Partnership
Bank of America Corporation
Robeco Investment Management
Morgan Stanley
William Blair Investment Management
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
D. E. Shaw & Co

View all funds holding Halozyme Therapeutics